Newsroom Newsroom Press Releases Events & Presentations News Articles Media Center Recent Press Releases March 14, 2023 Frontier Medicines to Spotlight Lead Candidate, Novel Dual KRASG12C Inhibitor FMC-376, and the Frontier™ Platform at the 2023 AACR Annual Meeting View Release February 28, 2023 Frontier Medicines Expands Leadership Team with Addition of Christo Shalish as Head of Business Development View Release January 5, 2023 Frontier Medicines Announces Advancement of Second and Third Programs Under Global Partnership with AbbVie View Release Read All Press Releases Events & Presentations UPCOMING EVENTS There are currently no upcoming events scheduled PAST EVENTS Presentation | January 11, 2023, 01:00 PM EDT J.P. Morgan Healthcare Conference Accessible by Registered Conference Attendees Select Media Coverage July 20, 2021 The Boston Globe: South San Francisco biotech to set up lab in Boston Read Article July 19, 2021 San Francisco Business Times: With focus on the 'undruggable,' Peninsula biotech raises $88.5M from IPO-minded investors Read Article July 19, 2021 Endpoint News: Months after Amgen's landmark KRAS approval, Chris Varma bags a crossover round for next-gen candidate Read Article Read All News Media Center Media Contact Contact PR Team Logos Click on the links below to download a high resolution image of the Frontier Medicines logo Download Image Download Image Download Image Download Image
March 14, 2023 Frontier Medicines to Spotlight Lead Candidate, Novel Dual KRASG12C Inhibitor FMC-376, and the Frontier™ Platform at the 2023 AACR Annual Meeting View Release
February 28, 2023 Frontier Medicines Expands Leadership Team with Addition of Christo Shalish as Head of Business Development View Release
January 5, 2023 Frontier Medicines Announces Advancement of Second and Third Programs Under Global Partnership with AbbVie View Release
Presentation | January 11, 2023, 01:00 PM EDT J.P. Morgan Healthcare Conference Accessible by Registered Conference Attendees
July 19, 2021 San Francisco Business Times: With focus on the 'undruggable,' Peninsula biotech raises $88.5M from IPO-minded investors Read Article
July 19, 2021 Endpoint News: Months after Amgen's landmark KRAS approval, Chris Varma bags a crossover round for next-gen candidate Read Article